A
Anna V. Forsythe
Researcher at University of Melbourne
Publications - 27
Citations - 1705
Anna V. Forsythe is an academic researcher from University of Melbourne. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 4 publications receiving 1464 citations.
Papers
More filters
Journal ArticleDOI
Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians
John D. Mathews,Anna V. Forsythe,Zoe Brady,Martin W Butler,Stacy Goergen,Graham Byrnes,Graham G. Giles,Anthony Wallace,Philip R Anderson,Philip R Anderson,Tenniel Guiver,Paul McGale,Timothy M. Cain,James G. Dowty,Adrian Bickerstaffe,Sarah C. Darby +15 more
TL;DR: The increased incidence of cancer after CT scan exposure in this cohort was mostly due to irradiation, and future CT scans should be limited to situations where there is a definite clinical indication, with every scan optimised to provide a diagnostic CT image at the lowest possible radiation dose.
Journal ArticleDOI
The changing use of pediatric CT in Australia
TL;DR: Significant increases in the rate of pediatric CT scanning have occurred in Australia and this rate has stabilized since 2000, possibly a result of better understanding of cancer risks.
Journal ArticleDOI
Humanistic and Economic Burden of Conversion Therapy Among LGBTQ Youths in the United States
TL;DR: It is suggested that there is a high economic burden and high societal costs associated with SOGICE and identifies additional research questions regarding the roles of private and public funding in supporting this harmful practice.
Journal ArticleDOI
Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses
David M. Halpin,Adrian Paul J Rabe,Wei Jie Loke,Stacy Grieve,Patrick Daniele,Sang-Youn Hwang,Anna V. Forsythe +6 more
TL;DR: In high-quality studies included, patients with asthma were not at significantly higher odds for adverse COVID-19–related outcomes, while patients with COPD were at higher odds.
Journal ArticleDOI
Non-small cell lung cancer with EGFR exon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes
Christina S Kwon,Huamao Mark Lin,Victoria Crossland,Eric N. Churchill,Eileen Curran,Anna V. Forsythe,Dimitrios Tomaras,Sai-Hong Ignatius Ou +7 more
TL;DR: Conventional treatments used in patients with EGFR exon 20 insertion mutation-positive NSCLC have limited efficacy, though chemotherapy appeared to be associated with better response and survival outcomes than non-exon 20 targeting EGFR-TKIs and IO agents.